| Title | Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases. |
| Publication Type | Journal Article |
| Year of Publication | 2007 |
| Authors | Bruce, Robert D., and Frederick L. Altice |
| Journal | The American journal of drug and alcohol abuse |
| Volume | 33 |
| Issue | 6 |
| Pagination | 869-74 |
| Date Published | 2007 |
| ISSN | 0095-2990 |
| Keywords | Adult, Alanine Transaminase, Aspartate Aminotransferases, Bipolar Disorder, Buprenorphine, Cocaine-Related Disorders, Female, Hepatitis B virus, Hepatitis C, Humans, Liver, Liver Function Tests, Male, Naloxone, Narcotic Antagonists, Needle Sharing, Opioid-Related Disorders, RNA, Viral, Transaminases |
| Abstract | Hepatitis C virus (HCV) is the most prevalent chronic viral illness in the United States. Many individuals with virus HCV are opioid dependent requiring treatment with opiate substitution treatment such as buprenorphine. Previous reports in the literature have suggested hepatotoxicity with buprenorphine tempering initial enthusiasm of the safety of buprenorphine in HCV-infected patients. |
| DOI | 10.1007/s11904-011-0095-3 |
| Alternate Journal | Am J Drug Alcohol Abuse |
